Drug Shortage Report for GLICLAZIDE MR
Report ID | 223456 |
Drug Identification Number | 02524856 |
Brand name | GLICLAZIDE MR |
Common or Proper name | GLICLAZIDE MR |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 30MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-03-26 |
Estimated end date | 2024-05-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-26 |
Company comments | on allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-03-26 | French | Compare |
v1 | 2024-03-26 | English | Compare |
Showing 1 to 2 of 2